Motor fluctuations and dyskinesias in Parkinson's disease: Clinical manifestations
β Scribed by Joseph Jankovic
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 93 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Fluctuations in the symptoms of Parkinson's disease (PD), such as wearing-off and on-off effects, and dyskinesias are related to a variety of factors, including duration and dosage of levodopa, age at onset, stress, sleep, food intake, and other pharmacokinetic and pharmacodynamic mechanisms. The majority of patients, particularly those with young onset of PD, experience these levodopa-related adverse effects after a few years of treatment. Assessment of these motor complications is difficult because of the marked clinical variability between and within patients. Daily diaries have been used in clinical trials designed to assess the effects of various pharmacological and surgical interventions on motor fluctuations and dyskinesias. The most common type of dyskinesia, called "peak-dose dyskinesia", usually consists of stereotypical choreic or ballistic movements involving the head, trunk, and limbs, and occasionally, the respiratory muscles, whereas tremor and punding are less-common complications. Dystonia is also typically seen in patients with diphasic dyskinesia and wearing-off effect. Recognition of the full spectrum of clinical phenomenology of levodopa-related motor complications is essential for their treatment and prevention.
π SIMILAR VOLUMES
## Abstract The impact of dyskinesias and motor fluctuations on quality of life (QOL) at various stages in the course of Parkinson's disease (PD) is not well understood. In 301 subjects with early PD enrolled in a clinical trial (CALMβPD), we quantified the impact of motor complications on QOL and
There are some confusing details in the recent Annals article by the Parkinson Study Group (PSG), concerning the use of entacapone.'
We read with interest the abstract by Olson et al. (I). They showed that gabapentin improves rigidity, bradykinesia, and tremor in parkinsonism and Parkinson's disease (PD). We administered gabapentin, 900 mg per day, in an open trial to seven nondemented patients with PD who had painful dystonia,
In questioning the diagnosis of a What is it? case (l), Quinn and Hardie (2) state that in their experience linear streaks of increased signal in the putamen on magnetic resonance imaging (MRI) are not seen in Huntington's disease but were seen in four of their cases of neuroacanthocytosis (3). In t